Sanofi-aventis Canada Inc has recalled two lots of its 0.15mg/0.15mL (child sized) Allerject auto-injectors due to a manufacturing defect that may prevent the device from working properly. Note that Allerject is the Canadian equivalent of the Auvi-Q sold in the US.
The defect, which affects the needle portion of the auto-injector, may prevent epinephrine from being delivered during an emergency posing a serious health risk to a child being treated for an anaphylactic reaction.
If you purchased an Allerject 0.15mg/0.15mL auto-injector in Canada on or after June 1, check to see if the lot numbers match 2857508 or 2857505. If so, make sure to follow the instructions in this press release issued by the company earlier today.
Source: Press Release – PR Newswire
